Literature DB >> 8657741

Induction of morphological and functional differentiation of human promyelocytic leukemia cells (HL-60) by Tubeimoside 1.

L Yu1, R Ma, T Yu.   

Abstract

Two functional parameters evaluated by nitroblue tetrazolium (NBT) dye reduction and zymosan particle phagocytosis and a morphological change assessed by the Wright-Giemsa stain of human promyelocytic leukemia cells (HL-60 cells) were used to determine the extent of HL-60 cell differentiation induced by tubeimoside 1. The results revealed that under the action of tubeimoside 1, HL-60 cells could be induced to differentiate to more mature cells with the functional characteristics of granulocytes. Therefore, tubeimoside 1 could be considered as a promising antileukemic agent for further animal trials.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8657741     DOI: 10.1055/s-2006-957831

Source DB:  PubMed          Journal:  Planta Med        ISSN: 0032-0943            Impact factor:   3.352


  3 in total

1.  Anti-microtubule activity of tubeimoside I and its colchicine binding site of tubulin.

Authors:  Rundi Ma; Gang Song; Wenbing You; Lijian Yu; Weiming Su; Mingneng Liao; Yongping Zhang; Laizhen Huang; Xiaoyu Zhang; Tingxi Yu
Journal:  Cancer Chemother Pharmacol       Date:  2007-11-21       Impact factor: 3.333

Review 2.  Tubeimoside-1: A review of its antitumor effects, pharmacokinetics, toxicity, and targeting preparations.

Authors:  Chang-Lin Wang; Ming-Zhou Gao; Dong-Mei Gao; Ying-Hui Guo; Zhan Gao; Xiang-Ju Gao; Jie-Qiong Wang; Ming-Qi Qiao
Journal:  Front Pharmacol       Date:  2022-07-15       Impact factor: 5.988

3.  Research on the interaction between tubeimoside 1 and HepG2 cells using the microscopic imaging and fluorescent spectra method.

Authors:  Xiaogang Lin; Wenchao Li; Changbin Ye; Xiaozhu Liu; Hao Zhu; Wenbing Peng; Jie Rong
Journal:  Comput Math Methods Med       Date:  2014-05-14       Impact factor: 2.238

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.